Atlas Trials

Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

Clinical trial NCT00965250 · COMPLETED

Trial details

NCT number
NCT00965250
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
ThymomaThymic CarcinomaThymic CarcinoidThymic Neuroendocrine Tumors
Start date
2009-08-01
Primary completion
2012-03-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.